INOVIQ Ltd

A$0.13As of Sun 8 Nov 2026, 12:00 UTC
ASX:IIQHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (17.15%)
Div yield —
ROE (42.16%)
Diagnostics & Research
Beta (5Y) 1.60
PE TTM —
TSR TTM (62.14%)
Mkt cap A$18.65M
ROIC (27.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.132
(0.23%)
(82.77%)
Hold 12|6|9|7|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
(1.66%)
7.78%
10.13%
11.32%
Revenue$M
1.340
1.304
1.322
1.298
(2.82%)
(3.10%)
(2.19%)
(3.52%)
Peers (US$12.76M)
Cap (US$)
PE
12.89M
99.65x
Capital
TTM
5Y
10Y
Leveragex
4.341
0.042
0.044
EBIT/Intx
0.242
0.431
0.325
Own earn%
798.32
74.25
62.21
Sh yield%
55.64
37.06
39.25
Owners
Insiders/Inst%
11.89
64.43
Short interest%
4.84
SBC / revenue%
4.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
3–11
$1 testx
0.2
Incr. ROIC%
23